Abridge, a generative AI platform for clinical conversations, has announced $300M in Series E funding led by Andreessen Horowitz (a16z), with participation from Khosla Ventures. The investment will accelerate the company's mission to transform how care is delivered, documented, and reimbursed, starting at the point of care.
The U.S. healthcare system spends nearly $1.5 trillion annually on administrative costs, with a significant portion tied to clinical documentation and revenue cycle management workflows. These complex processes require accurately capturing details from clinical conversations, translating them into thousands of billing codes, and navigating payer-specific requirements. This burden has increasingly fallen on clinicians, contributing to burnout and delaying reimbursement.
Abridge's platform addresses this challenge by moving beyond simple documentation to embed revenue cycle intelligence directly into clinical conversations. The platform's Contextual Reasoning Engine supports the latest guidelines and risk adjustment models, including CMS-HCC Version 28, transforming patient conversations into compliant documentation at the point of care.
The system captures every appropriate Hierarchical Condition Category (HCC) code with supporting evidence, enabling RCM teams to submit accurate claims without querying clinicians after visits. This approach reduces unnecessary back-and-forth communications, achieves faster reimbursement cycles, and minimizes the risk of denials.
Abridge has deployed its enterprise-grade AI platform at 150 of the largest and most complex health systems in the country over the past two years. The company now serves conversations across 55 specialties and 28 languages, and is on track to support clinicians across more than 50 million medical conversations this year. Over 90% of clinicians who start using Abridge continue to use the platform in a meaningful way.
"Every medical conversation is rich with the signals our healthcare system depends on. Abridge activates those signals in the background, silently handling the complexity so clinicians can focus on the human moments that matter," said Dr. Shiv Rao, CEO and co-founder of Abridge. "We reduce the burden, restore time, and help make care about the people at the heart of it all."
The new capital will enable Abridge to expand its platform capabilities and reach more healthcare organizations seeking to streamline administrative processes while improving care delivery.
Click here for the original news story.